25 February 2021 - Deborah Wilkes
HRA Pharma picks up the OTCToolbox Consumer Healthcare Industry (CHi) Award for Regulatory Achievement of the Year for a “milestone achievement” with its ellaOne brand in Italy.
During 2020, ellaOne became the first emergency contraceptive pill in Italy to be made available without a prescription to women under 18 years of age.
At the time, David Wright, HRA Pharma’s chief executive officer, described the development as a “milestone achievement”.
Commenting on HRA Pharma winning the CHi Award, Chief Scientific Officer Paul Carter said: “On behalf of HRA Pharma, I would like to say a huge thank you to OTCToolbox for selecting ellaOne to win its CHi Award, which recognises ellaOne becoming the first emergency contraceptive pill to be made available over the counter for under 18s in Italy.”
“The lowering of this age limit was an incredible achievement for HRA Pharma and our Italy Hub,” continued Carter. “It is an honour to know this landmark in women’s health is being named as a Regulatory Achievement of the Year.”
“At HRA Pharma, we believe it is crucial that young girls have access to emergency contraception should they need it, and we have a longstanding commitment to ensuring that belief becomes a reality across the globe,” he added.
The best in business development and innovation
The OTCToolbox CHi Awards honour the best in business development and innovation around the world.
Regulatory Achievement of the Year was one of five CHi Awards presented during the OTCToolbox 2021 Consumer Healthcare BD&I Event on 25-26 February 2021.
- Transaction of the Year
- Business Development Team of the Year
- Innovation of the Year
- Regulatory Achievement of the Year
- Self-Care Initiative of the Year